Hostname: page-component-586b7cd67f-t8hqh Total loading time: 0 Render date: 2024-11-22T13:59:10.506Z Has data issue: false hasContentIssue false
  • English
  • Français

Clopenthixol: A Controlled Trial in Chronic Hospitalized Schizophrenic Patients

Published online by Cambridge University Press:  29 January 2018

S. K. Kordas ,
N. G. Kazamias ,
J. G. Georgas  and
J. G. Papadokostakis
S. K. Kordas
Affiliation:
2nd division of Dromokaïtion Hospital, Athens, Greece
N. G. Kazamias
Affiliation:
Dromokaïtion Hospital, Athens, Greece
J. G. Georgas
Affiliation:
The Athenian Institute of Anthropos, Athens, Greece
J. G. Papadokostakis
Affiliation:
Dromokaïtion Hospital, Athens, Greece
Get access Rights & Permissions [Opens in a new window]

Extract

Clopenthixol is a thiaxanthen derivative (Fig. 1). Its full name chemically is 2-chlor-9-[3-(N-B-hydroxyathylpiperazino)-propyliden]-thioxanthen. Numerous uncontrolled trials to date (2, 3, 4, 5, 6, 7) have reported success with this drug in the treatment of schizophrenia, mania and other psychotic disorders.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 114 , Issue 512 , July 1968 , pp. 833 - 836
Copyright
Copyright © Royal College of Psychiatrists, 1968 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Georgas, J. G. (1964). “Rater sensibility to behavioural and inferential phenomena of schizophrenics” Loyola Psychometric Laboratory, Publication No. 39, Loyola University, Chicago, Illinois.Google Scholar
2. Gross, H., und Kaltenbäck, E. (1962). “Sordinol, ein neues Neuroleptikum der Thiaxanthenreihe” Wien. Klin. Wschr., 74, 549–554.Google Scholar
3. Hildebrand, H. J. (1964). “Ergebnisse und erfahrungen mit dem neuroleptikum Ciatyl” Deutsch Med. Journal, 15, 242–246.Google Scholar
4. Marx, H., and Kruger, H. (1962). “Neue Gesichtspunkte in der Neuroleptischen Behandlung akuter und chronischer Psychosen” Nervenarzt, 33, 469–472.Google Scholar
5. Marx, H., (1966). “Über die neuroleptische Behandlung der Psychosen und die Bedeutung der Dauermedikation” Med. Welt., 17, 446–450.Google Scholar
6. Mayr, F., Fürtinger, H., Geyer, N., und Paier, G. (1962). “Vorläufige Ergebnisse mit Clopenthixol” Wien. med. Wschr., 112, 588.Google Scholar
7. Ravn, J. (1962). “Über die Behandlung 60 schizophrener Patienten mit Ciatyl” Med. Klinik, 57, 1227–1229.Google Scholar
8. Winer, B. J. (1962). Statistical Principles in Experimental Design. New York: McGraw-Hill.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.